{"id":348957,"date":"2025-08-25T16:10:43","date_gmt":"2025-08-25T16:10:43","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-kura-oncology\/"},"modified":"2025-08-25T16:10:43","modified_gmt":"2025-08-25T16:10:43","slug":"how-to-buy-kura-oncology","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/","title":{"rendered":"Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Kura Oncology, Inc. (KURA) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-348957","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Kura Oncology, Inc. (KURA) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Kura Oncology, Inc. (KURA) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Bu umut vadeden biyoteknoloji \u015firketi i\u00e7in g\u00fcncel fiyat analizi, 2025-2030 tahminleri ve ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile Kura Oncology, Inc. (KURA) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Bu umut vadeden biyoteknoloji \u015firketi i\u00e7in g\u00fcncel fiyat analizi, 2025-2030 tahminleri ve ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile Kura Oncology, Inc. (KURA) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin."},"intro":"Keskin kanser tedavilerine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Kura Oncology, bilimin hayat kurtaran potansiyelle bulu\u015ftu\u011fu hassas t\u0131bb\u0131n heyecan verici s\u0131n\u0131r\u0131n\u0131 temsil ediyor. Bu klinik a\u015famadaki biyoteknoloji \u015firketi kanser bak\u0131m\u0131n\u0131 devrim niteli\u011finde de\u011fi\u015ftirebilir ve bu, ila\u00e7 geli\u015ftirme alan\u0131n\u0131n y\u00fcksek riskli, y\u00fcksek getirili do\u011fas\u0131n\u0131 anlayan yat\u0131r\u0131mc\u0131lar i\u00e7in b\u00fcy\u00fcleyici bir f\u0131rsat sunar. KURA'y\u0131 neyin harekete ge\u00e7irdi\u011fini ve bu t\u0131bbi at\u0131l\u0131m hikayesinin bir par\u00e7as\u0131 nas\u0131l olabilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Keskin kanser tedavilerine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Kura Oncology, bilimin hayat kurtaran potansiyelle bulu\u015ftu\u011fu hassas t\u0131bb\u0131n heyecan verici s\u0131n\u0131r\u0131n\u0131 temsil ediyor. Bu klinik a\u015famadaki biyoteknoloji \u015firketi kanser bak\u0131m\u0131n\u0131 devrim niteli\u011finde de\u011fi\u015ftirebilir ve bu, ila\u00e7 geli\u015ftirme alan\u0131n\u0131n y\u00fcksek riskli, y\u00fcksek getirili do\u011fas\u0131n\u0131 anlayan yat\u0131r\u0131mc\u0131lar i\u00e7in b\u00fcy\u00fcleyici bir f\u0131rsat sunar. KURA'y\u0131 neyin harekete ge\u00e7irdi\u011fini ve bu t\u0131bbi at\u0131l\u0131m hikayesinin bir par\u00e7as\u0131 nas\u0131l olabilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 Kura Oncology Hisse Senedi Analizi: Mevcut Durum ve Gelecek Potansiyeli<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla, Kura Oncology, Inc. (KURA) NASDAQ borsas\u0131nda <strong>7,43 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Ancak as\u0131l \u00f6nemli olan \u015fudur - takviminize <strong>6 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin. Kura'n\u0131n 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayaca\u011f\u0131 bu tarih, ge\u00e7mi\u015f deneyimlerimize g\u00f6re hisse senedinde \u00f6nemli hareketlere yol a\u00e7abilir.<\/p> <h3>6 Kas\u0131m Neden Bu Kadar \u00d6nemli?<\/h3> <p>Biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131 ve finansal g\u00fcncellemelerle hayat bulur ya da biter. 7 A\u011fustos 2025 tarihli son kazan\u00e7 raporu, \u015firketin hisse ba\u015f\u0131na 0,90 $ tahminlerin alt\u0131nda kalarak -0,75 $ EPS bildirmesiyle beklentileri kar\u015f\u0131lamad\u0131. Bu hayal k\u0131r\u0131kl\u0131\u011f\u0131, hissenin mevcut d\u00fc\u015f\u00fck seviyelerine katk\u0131da bulundu.<\/p> <p>Benzer biyoteknoloji \u015firketlerine bak\u0131ld\u0131\u011f\u0131nda, kazan\u00e7 a\u00e7\u0131klamalar\u0131 genellikle an\u0131nda %5-15 fiyat dalgalanmalar\u0131na neden olur. KURA \u00f6zelinde, opsiyon piyasas\u0131 volatilite sinyalleri veriyor - 18 Temmuz 2025 tarihli 2,50 $ Put opsiyonu \"t\u00fcm hisse senedi opsiyonlar\u0131 aras\u0131nda en y\u00fcksek \u00f6rt\u00fck volatiliteye sahiplerden biri\" olarak <a href=\"https:\/\/www.nasdaq.com\/articles\/options-market-predicting-spike-kura-oncology-stock\">Nasdaq piyasa verileri<\/a> taraf\u0131ndan bildiriliyor. Bu, profesyonel yat\u0131r\u0131mc\u0131lar\u0131n b\u00fcy\u00fck hareketler bekledi\u011fini g\u00f6steriyor.<\/p> <h3>6 Ayl\u0131k Fiyat Yolculu\u011fu: Dalgalarla Dolu Bir S\u00fcr\u00fc\u015f<\/h3> <p>KURA'n\u0131n son alt\u0131 aydaki seyri kesinlikle s\u0131k\u0131c\u0131 olmad\u0131:<\/p> <ul> <li><strong>Ocak 2025<\/strong>: 8,71 $ ile ba\u015flad\u0131, erken umut verdi<\/li> <li><strong>Mart 2025<\/strong>: Daha geni\u015f biyoteknoloji sekt\u00f6r\u00fc endi\u015feleri aras\u0131nda yakla\u015f\u0131k 6,50 $ seviyesine d\u00fc\u015ft\u00fc<\/li> <li><strong>May\u0131s 2025<\/strong>: Olumlu klinik deneme s\u00f6ylentileriyle 7,20 $ seviyesine toparland\u0131<\/li> <li><strong>Temmuz 2025<\/strong>: Opsiyon yat\u0131r\u0131mc\u0131lar\u0131n\u0131n b\u00fcy\u00fck hareketlere bahis yapmas\u0131yla volatilite ya\u015fand\u0131<\/li> <li><strong>A\u011fustos 2025<\/strong>: 2. \u00e7eyrek kazan\u00e7 hayal k\u0131r\u0131kl\u0131\u011f\u0131ndan sonra 7,43 $ seviyesinde dengelendi<\/li> <\/ul> <p>Hisse senedi Ocak ay\u0131ndan bu yana %12,2 de\u011fer kaybetti ancak son bir ayda %22,79 ve \u00fc\u00e7 ayda %36,36 art\u0131\u015f g\u00f6stererek son d\u00f6nemde g\u00fc\u00e7 kazand\u0131. Bu ivme, yat\u0131r\u0131mc\u0131lar\u0131n olumlu geli\u015fmeler bekliyor olabilece\u011fini g\u00f6steriyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in i\u015fte heyecan verici k\u0131s\u0131m. Analistlerin g\u00f6r\u00fc\u015f\u00fc, son zorluklara ra\u011fmen b\u00fcy\u00fck \u00f6l\u00e7\u00fcde iyimser:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: Ortalama 24,69 $ (mevcut fiyata g\u00f6re %222 y\u00fckseli\u015f potansiyeli)<\/li> <li><strong>2026 Tahmini<\/strong>: 28-30 $ aral\u0131\u011f\u0131 (b\u00fcy\u00fcme evresi devam ediyor)<\/li> <li><strong>2028 Projeksiyonu<\/strong>: 35-40 $ (potansiyel ticarile\u015fme a\u015famas\u0131)<\/li> <li><strong>2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 45-50 $+ (yerle\u015fik gelir ak\u0131\u015flar\u0131)<\/li> <\/ul> <p><a href=\"https:\/\/stockscan.io\/stocks\/KURA\/forecast\">Stockscan.io<\/a> taraf\u0131ndan yap\u0131lan bu projeksiyonlar, ba\u015far\u0131l\u0131 klinik denemeler ve d\u00fczenleyici onaylar varsay\u0131m\u0131na dayan\u0131yor. En iyimser analistler Aral\u0131k 2025 i\u00e7in 39,19 $ \u00f6ng\u00f6r\u00fcrken, muhafazakar tahminler yakla\u015f\u0131k 10,19 $ civar\u0131nda.<\/p> <p><strong>Sonu\u00e7<\/strong>: R\u0130SK TOLERANSI Y\u00dcKSEK yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM \u00f6nerisi. KURA'y\u0131 takip eden 11 analist firmas\u0131n\u0131n tamam\u0131 \"Al\" veya \"G\u00fc\u00e7l\u00fc Al\" derecelendirmesi veriyor ve ortalama fiyat hedefi 24,45 $ ile %219 y\u00fckseli\u015f potansiyeli sunuyor.<\/p> <h2>\u26a0\ufe0f Riskler ve Getiriler Aras\u0131ndaki Dengeyi Anlamak<\/h2> <h3>Ba\u015fl\u0131ca Risk Fakt\u00f6rleri<\/h3> <ol> <li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131\u011f\u0131<\/strong>: Deneysel ila\u00e7lar\u0131n %90'\u0131 ba\u015far\u0131s\u0131z olur. Olumsuz deneme sonu\u00e7lar\u0131 hisseyi \u00e7\u00f6kertebilir<\/li> <li><strong>D\u00fczenleyici Engeller<\/strong>: FDA reddi piyasa de\u011ferinde milyarlarca dolar kayba yol a\u00e7abilir<\/li> <li><strong>Nakit T\u00fcketimi<\/strong>: Kura ge\u00e7en y\u0131l 197 milyon $ yakt\u0131, k\u00e2r marjlar\u0131 -%236 negatif<\/li> <li><strong>Rekabet<\/strong>: Daha b\u00fcy\u00fck ila\u00e7 \u015firketleri derin ceplerle rakip tedaviler geli\u015ftirebilir<\/li> <li><strong>Hisse Seyrelme Riski<\/strong>: Sermaye art\u0131r\u0131m\u0131 i\u00e7in hisse senedi ihra\u00e7 edilmesi mevcut hisseleri seyreltebilir<\/li> <\/ol> <h3>2025 \u0130\u00e7in Olumlu \u0130\u015faretler<\/h3> <ol> <li><strong>Analist G\u00f6r\u00fc\u015f Birli\u011fi<\/strong>: %100 \"Al\" derecelendirmesi, \"Sat\" \u00f6nerisi yok<\/li> <li><strong>Son Ortakl\u0131k<\/strong>: Ziftomenib geli\u015ftirme i\u00e7in Kyowa Kirin ile k\u00fcresel i\u015f birli\u011fi<\/li> <li><strong>\u0130la\u00e7 Aday\u0131 \u0130lerlemesi<\/strong>: Farkl\u0131 kanser t\u00fcrlerinde umut vadeden \u00e7oklu klinik denemeler<\/li> <li><strong>Sekt\u00f6r Trendi<\/strong>: Hassas t\u0131p onkoloji tedavisinin gelece\u011fi<\/li> <li><strong>K\u0131sa Pozisyon Oran\u0131<\/strong>: D\u00fc\u015f\u00fck k\u0131sa pozisyon oran\u0131, azalan d\u00fc\u015f\u00fc\u015f beklentisi<\/li> <\/ol> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <p>T\u00fcm verileri analiz ettikten sonra profesyonel tavsiyem \u015fudur:<\/p> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5'inden fazlas\u0131n\u0131 y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>Ortalama Maliyetle Al\u0131m<\/strong>: Zamanlama riskini azaltmak i\u00e7in toplu de\u011fil par\u00e7a par\u00e7a al\u0131m yap\u0131n<\/li> <li><strong>Zarar Durdur Emirleri Kullan\u0131n<\/strong>: Sermayenizi %15-20 zarar durdur emirleriyle koruyun<\/li> <li><strong>6 Kas\u0131m'\u0131 Takip Edin<\/strong>: 3. \u00e7eyrek kazan\u00e7lar\u0131 b\u00fcy\u00fck hareket i\u00e7in tetikleyici olabilir<\/li> <\/ol> <p>Ve mizahi yorumum: \"Biyoteknolojiye yat\u0131r\u0131m yapmak fl\u00f6rt etmek gibidir - kalbiniz k\u0131r\u0131labilir ama i\u015fe yararsa kesinlikle b\u00fcy\u00fcleyicidir. Sadece ilk bulu\u015fmada d\u00fc\u011f\u00fcn paras\u0131n\u0131 yat\u0131rmay\u0131n!\"<\/p> <h2>\u2705 Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir i\u015flem platformu se\u00e7in<\/td><td>NASDAQ listeleri ve par\u00e7al\u0131 hisse sunan platformlar\u0131 tercih edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>\u00c7o\u011fu platform kimlik ve adres kan\u0131t\u0131 ister<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"KURA\" aramas\u0131 yap\u0131n<\/td><td>\u015eirket ad\u0131 yerine borsa sembol\u00fcn\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>6<\/td><td>Emir detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td><td>Komisyon \u00fccretleri ve toplam maliyeti kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Al\u0131m\u0131 ger\u00e7ekle\u015ftirin<\/td><td>\u0130\u015flemi onaylay\u0131n ve fiyat uyar\u0131lar\u0131 kurun<\/td><\/tr> <tr><td>8<\/td><td>Pozisyonu izleyin<\/td><td>Haberleri takip edin ve \u00e7\u0131k\u0131\u015f stratejileri belirleyin<\/td><\/tr> <tr><td>9<\/td><td>Vergi etkilerini de\u011ferlendirin<\/td><td>Sermaye kazanc\u0131 vergilendirmesini anlay\u0131n<\/td><\/tr> <tr><td>10<\/td><td>Temett\u00fcleri yeniden yat\u0131r\u0131n<\/td><td>KURA hen\u00fcz temett\u00fc \u00f6demiyor, ancak gelecekteki gelir i\u00e7in plan yap\u0131n<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Pocket Option Neden Mant\u0131kl\u0131?<\/h2> <p>Biyoteknoloji yat\u0131r\u0131mlar\u0131na ad\u0131m atmak isteyenler i\u00e7in Pocket Option, yeni ba\u015flayan yat\u0131r\u0131mc\u0131lara m\u00fckemmel uyum sa\u011flayan birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Sadece 5 $ minimum depozito<\/strong> - Stratejileri d\u00fc\u015f\u00fck riskle test edebilirsiniz<\/li> <li><strong>Y\u0131ld\u0131r\u0131m h\u0131z\u0131nda do\u011frulama<\/strong> - Basit belge y\u00fcklemesiyle dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>100'den fazla para \u00e7ekme y\u00f6ntemi<\/strong> - Kripto, e-c\u00fczdan veya geleneksel bankac\u0131l\u0131k ile kar\u0131n\u0131za eri\u015fin<\/li> <li><strong>Par\u00e7al\u0131 hisse imkan\u0131<\/strong> - Pahal\u0131 hisselerin tamam\u0131n\u0131 almadan par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li> <li><strong>Anl\u0131k piyasa verileri<\/strong> - En g\u00fcncel fiyatlarla bilin\u00e7li kararlar verin<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, karma\u015f\u0131k biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131 borsa piyasas\u0131na yeni girenler i\u00e7in \u00e7ok daha eri\u015filebilir k\u0131lar.<\/p> <h2>\ud83c\udf0d 2025'te Kura Oncology: Hassas T\u0131bb\u0131n \u00d6nc\u00fcs\u00fc<\/h2> <p>Kura Oncology, kanser tedavisinde yenili\u011fin \u00f6n saflar\u0131nda yer al\u0131yor. \u015eirket, sa\u011fl\u0131kl\u0131 h\u00fccrelere zarar vermeden belirli kanser mutasyonlar\u0131n\u0131 hedefleyen hassas ila\u00e7lar geli\u015ftiriyor - bunu kanser tedavisi i\u00e7in ak\u0131ll\u0131 bombalar ile hal\u0131 bombalamas\u0131 aras\u0131ndaki fark olarak d\u00fc\u015f\u00fcnebilirsiniz.<\/p> <p>\u0130la\u00e7 adaylar\u0131 \u015funlar\u0131 i\u00e7erir:<\/p> <ul> <li><strong>Ziftomenib<\/strong>: Akut l\u00f6semiler i\u00e7in Menin inhibit\u00f6r\u00fc (Kyowa Kirin ile ortakl\u0131k)<\/li> <li><strong>Tipifarnib<\/strong>: Ba\u015f ve boyun kanserleri i\u00e7in Farnesil transferaz inhibit\u00f6r\u00fc<\/li> <li><strong>KO-2806<\/strong>: Erken geli\u015ftirme a\u015famas\u0131nda yeni nesil kanser tedavisi<\/li> <\/ul> <p>\u015eirketin i\u015f modeli b\u00fcy\u00fck \u00f6l\u00e7\u00fcde stratejik ortakl\u0131klara dayan\u0131yor; <a href=\"https:\/\/dcfmodeling.com\/blogs\/history\/kura-history-mission-ownership\">Nisan 2025 verilerine<\/a> g\u00f6re i\u015f birli\u011fi gelirleri gelirlerinin yakla\u015f\u0131k %95'ini olu\u015fturuyor. Bu yakla\u015f\u0131m, geli\u015ftirme maliyetlerini ve riskleri payla\u015f\u0131rken pazara \u00e7\u0131k\u0131\u015f s\u00fcresini h\u0131zland\u0131r\u0131yor.<\/p> <p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Kura Oncology CEO'su Troy Wilson, EY Giri\u015fimci Of The Year 2025 Pasifik G\u00fcneybat\u0131 \u00d6d\u00fcl\u00fc'n\u00fc kazand\u0131 - bu \u00f6d\u00fcl, \u015firketin yenilik\u00e7i yakla\u015f\u0131m\u0131n\u0131 ve rekabet\u00e7i biyoteknoloji alan\u0131ndaki liderli\u011fini vurguluyor. Bu t\u00fcr \u00f6d\u00fcller genellikle \u00f6nemli kurumsal geli\u015fmeler ve artan yat\u0131r\u0131mc\u0131 ilgisinden \u00f6nce gelir.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Kura Oncology Hisse Senedi Analizi: Mevcut Durum ve Gelecek Potansiyeli<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla, Kura Oncology, Inc. (KURA) NASDAQ borsas\u0131nda <strong>7,43 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Ancak as\u0131l \u00f6nemli olan \u015fudur &#8211; takviminize <strong>6 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin. Kura&#8217;n\u0131n 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayaca\u011f\u0131 bu tarih, ge\u00e7mi\u015f deneyimlerimize g\u00f6re hisse senedinde \u00f6nemli hareketlere yol a\u00e7abilir.<\/p>\n<h3>6 Kas\u0131m Neden Bu Kadar \u00d6nemli?<\/h3>\n<p>Biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131 ve finansal g\u00fcncellemelerle hayat bulur ya da biter. 7 A\u011fustos 2025 tarihli son kazan\u00e7 raporu, \u015firketin hisse ba\u015f\u0131na 0,90 $ tahminlerin alt\u0131nda kalarak -0,75 $ EPS bildirmesiyle beklentileri kar\u015f\u0131lamad\u0131. Bu hayal k\u0131r\u0131kl\u0131\u011f\u0131, hissenin mevcut d\u00fc\u015f\u00fck seviyelerine katk\u0131da bulundu.<\/p>\n<p>Benzer biyoteknoloji \u015firketlerine bak\u0131ld\u0131\u011f\u0131nda, kazan\u00e7 a\u00e7\u0131klamalar\u0131 genellikle an\u0131nda %5-15 fiyat dalgalanmalar\u0131na neden olur. KURA \u00f6zelinde, opsiyon piyasas\u0131 volatilite sinyalleri veriyor &#8211; 18 Temmuz 2025 tarihli 2,50 $ Put opsiyonu &#8220;t\u00fcm hisse senedi opsiyonlar\u0131 aras\u0131nda en y\u00fcksek \u00f6rt\u00fck volatiliteye sahiplerden biri&#8221; olarak <a href=\"https:\/\/www.nasdaq.com\/articles\/options-market-predicting-spike-kura-oncology-stock\">Nasdaq piyasa verileri<\/a> taraf\u0131ndan bildiriliyor. Bu, profesyonel yat\u0131r\u0131mc\u0131lar\u0131n b\u00fcy\u00fck hareketler bekledi\u011fini g\u00f6steriyor.<\/p>\n<h3>6 Ayl\u0131k Fiyat Yolculu\u011fu: Dalgalarla Dolu Bir S\u00fcr\u00fc\u015f<\/h3>\n<p>KURA&#8217;n\u0131n son alt\u0131 aydaki seyri kesinlikle s\u0131k\u0131c\u0131 olmad\u0131:<\/p>\n<ul>\n<li><strong>Ocak 2025<\/strong>: 8,71 $ ile ba\u015flad\u0131, erken umut verdi<\/li>\n<li><strong>Mart 2025<\/strong>: Daha geni\u015f biyoteknoloji sekt\u00f6r\u00fc endi\u015feleri aras\u0131nda yakla\u015f\u0131k 6,50 $ seviyesine d\u00fc\u015ft\u00fc<\/li>\n<li><strong>May\u0131s 2025<\/strong>: Olumlu klinik deneme s\u00f6ylentileriyle 7,20 $ seviyesine toparland\u0131<\/li>\n<li><strong>Temmuz 2025<\/strong>: Opsiyon yat\u0131r\u0131mc\u0131lar\u0131n\u0131n b\u00fcy\u00fck hareketlere bahis yapmas\u0131yla volatilite ya\u015fand\u0131<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 2. \u00e7eyrek kazan\u00e7 hayal k\u0131r\u0131kl\u0131\u011f\u0131ndan sonra 7,43 $ seviyesinde dengelendi<\/li>\n<\/ul>\n<p>Hisse senedi Ocak ay\u0131ndan bu yana %12,2 de\u011fer kaybetti ancak son bir ayda %22,79 ve \u00fc\u00e7 ayda %36,36 art\u0131\u015f g\u00f6stererek son d\u00f6nemde g\u00fc\u00e7 kazand\u0131. Bu ivme, yat\u0131r\u0131mc\u0131lar\u0131n olumlu geli\u015fmeler bekliyor olabilece\u011fini g\u00f6steriyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in i\u015fte heyecan verici k\u0131s\u0131m. Analistlerin g\u00f6r\u00fc\u015f\u00fc, son zorluklara ra\u011fmen b\u00fcy\u00fck \u00f6l\u00e7\u00fcde iyimser:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: Ortalama 24,69 $ (mevcut fiyata g\u00f6re %222 y\u00fckseli\u015f potansiyeli)<\/li>\n<li><strong>2026 Tahmini<\/strong>: 28-30 $ aral\u0131\u011f\u0131 (b\u00fcy\u00fcme evresi devam ediyor)<\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: 35-40 $ (potansiyel ticarile\u015fme a\u015famas\u0131)<\/li>\n<li><strong>2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 45-50 $+ (yerle\u015fik gelir ak\u0131\u015flar\u0131)<\/li>\n<\/ul>\n<p><a href=\"https:\/\/stockscan.io\/stocks\/KURA\/forecast\">Stockscan.io<\/a> taraf\u0131ndan yap\u0131lan bu projeksiyonlar, ba\u015far\u0131l\u0131 klinik denemeler ve d\u00fczenleyici onaylar varsay\u0131m\u0131na dayan\u0131yor. En iyimser analistler Aral\u0131k 2025 i\u00e7in 39,19 $ \u00f6ng\u00f6r\u00fcrken, muhafazakar tahminler yakla\u015f\u0131k 10,19 $ civar\u0131nda.<\/p>\n<p><strong>Sonu\u00e7<\/strong>: R\u0130SK TOLERANSI Y\u00dcKSEK yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM \u00f6nerisi. KURA&#8217;y\u0131 takip eden 11 analist firmas\u0131n\u0131n tamam\u0131 &#8220;Al&#8221; veya &#8220;G\u00fc\u00e7l\u00fc Al&#8221; derecelendirmesi veriyor ve ortalama fiyat hedefi 24,45 $ ile %219 y\u00fckseli\u015f potansiyeli sunuyor.<\/p>\n<h2>\u26a0\ufe0f Riskler ve Getiriler Aras\u0131ndaki Dengeyi Anlamak<\/h2>\n<h3>Ba\u015fl\u0131ca Risk Fakt\u00f6rleri<\/h3>\n<ol>\n<li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131\u011f\u0131<\/strong>: Deneysel ila\u00e7lar\u0131n %90&#8217;\u0131 ba\u015far\u0131s\u0131z olur. Olumsuz deneme sonu\u00e7lar\u0131 hisseyi \u00e7\u00f6kertebilir<\/li>\n<li><strong>D\u00fczenleyici Engeller<\/strong>: FDA reddi piyasa de\u011ferinde milyarlarca dolar kayba yol a\u00e7abilir<\/li>\n<li><strong>Nakit T\u00fcketimi<\/strong>: Kura ge\u00e7en y\u0131l 197 milyon $ yakt\u0131, k\u00e2r marjlar\u0131 -%236 negatif<\/li>\n<li><strong>Rekabet<\/strong>: Daha b\u00fcy\u00fck ila\u00e7 \u015firketleri derin ceplerle rakip tedaviler geli\u015ftirebilir<\/li>\n<li><strong>Hisse Seyrelme Riski<\/strong>: Sermaye art\u0131r\u0131m\u0131 i\u00e7in hisse senedi ihra\u00e7 edilmesi mevcut hisseleri seyreltebilir<\/li>\n<\/ol>\n<h3>2025 \u0130\u00e7in Olumlu \u0130\u015faretler<\/h3>\n<ol>\n<li><strong>Analist G\u00f6r\u00fc\u015f Birli\u011fi<\/strong>: %100 &#8220;Al&#8221; derecelendirmesi, &#8220;Sat&#8221; \u00f6nerisi yok<\/li>\n<li><strong>Son Ortakl\u0131k<\/strong>: Ziftomenib geli\u015ftirme i\u00e7in Kyowa Kirin ile k\u00fcresel i\u015f birli\u011fi<\/li>\n<li><strong>\u0130la\u00e7 Aday\u0131 \u0130lerlemesi<\/strong>: Farkl\u0131 kanser t\u00fcrlerinde umut vadeden \u00e7oklu klinik denemeler<\/li>\n<li><strong>Sekt\u00f6r Trendi<\/strong>: Hassas t\u0131p onkoloji tedavisinin gelece\u011fi<\/li>\n<li><strong>K\u0131sa Pozisyon Oran\u0131<\/strong>: D\u00fc\u015f\u00fck k\u0131sa pozisyon oran\u0131, azalan d\u00fc\u015f\u00fc\u015f beklentisi<\/li>\n<\/ol>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<p>T\u00fcm verileri analiz ettikten sonra profesyonel tavsiyem \u015fudur:<\/p>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5&#8217;inden fazlas\u0131n\u0131 y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>Ortalama Maliyetle Al\u0131m<\/strong>: Zamanlama riskini azaltmak i\u00e7in toplu de\u011fil par\u00e7a par\u00e7a al\u0131m yap\u0131n<\/li>\n<li><strong>Zarar Durdur Emirleri Kullan\u0131n<\/strong>: Sermayenizi %15-20 zarar durdur emirleriyle koruyun<\/li>\n<li><strong>6 Kas\u0131m&#8217;\u0131 Takip Edin<\/strong>: 3. \u00e7eyrek kazan\u00e7lar\u0131 b\u00fcy\u00fck hareket i\u00e7in tetikleyici olabilir<\/li>\n<\/ol>\n<p>Ve mizahi yorumum: &#8220;Biyoteknolojiye yat\u0131r\u0131m yapmak fl\u00f6rt etmek gibidir &#8211; kalbiniz k\u0131r\u0131labilir ama i\u015fe yararsa kesinlikle b\u00fcy\u00fcleyicidir. Sadece ilk bulu\u015fmada d\u00fc\u011f\u00fcn paras\u0131n\u0131 yat\u0131rmay\u0131n!&#8221;<\/p>\n<h2>\u2705 Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir i\u015flem platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve par\u00e7al\u0131 hisse sunan platformlar\u0131 tercih edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>\u00c7o\u011fu platform kimlik ve adres kan\u0131t\u0131 ister<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;KURA&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 yerine borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Emir detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td>\n<td>Komisyon \u00fccretleri ve toplam maliyeti kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Al\u0131m\u0131 ger\u00e7ekle\u015ftirin<\/td>\n<td>\u0130\u015flemi onaylay\u0131n ve fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Pozisyonu izleyin<\/td>\n<td>Haberleri takip edin ve \u00e7\u0131k\u0131\u015f stratejileri belirleyin<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Vergi etkilerini de\u011ferlendirin<\/td>\n<td>Sermaye kazanc\u0131 vergilendirmesini anlay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Temett\u00fcleri yeniden yat\u0131r\u0131n<\/td>\n<td>KURA hen\u00fcz temett\u00fc \u00f6demiyor, ancak gelecekteki gelir i\u00e7in plan yap\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Pocket Option Neden Mant\u0131kl\u0131?<\/h2>\n<p>Biyoteknoloji yat\u0131r\u0131mlar\u0131na ad\u0131m atmak isteyenler i\u00e7in Pocket Option, yeni ba\u015flayan yat\u0131r\u0131mc\u0131lara m\u00fckemmel uyum sa\u011flayan birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Sadece 5 $ minimum depozito<\/strong> &#8211; Stratejileri d\u00fc\u015f\u00fck riskle test edebilirsiniz<\/li>\n<li><strong>Y\u0131ld\u0131r\u0131m h\u0131z\u0131nda do\u011frulama<\/strong> &#8211; Basit belge y\u00fcklemesiyle dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>100&#8217;den fazla para \u00e7ekme y\u00f6ntemi<\/strong> &#8211; Kripto, e-c\u00fczdan veya geleneksel bankac\u0131l\u0131k ile kar\u0131n\u0131za eri\u015fin<\/li>\n<li><strong>Par\u00e7al\u0131 hisse imkan\u0131<\/strong> &#8211; Pahal\u0131 hisselerin tamam\u0131n\u0131 almadan par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li>\n<li><strong>Anl\u0131k piyasa verileri<\/strong> &#8211; En g\u00fcncel fiyatlarla bilin\u00e7li kararlar verin<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, karma\u015f\u0131k biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131 borsa piyasas\u0131na yeni girenler i\u00e7in \u00e7ok daha eri\u015filebilir k\u0131lar.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Kura Oncology: Hassas T\u0131bb\u0131n \u00d6nc\u00fcs\u00fc<\/h2>\n<p>Kura Oncology, kanser tedavisinde yenili\u011fin \u00f6n saflar\u0131nda yer al\u0131yor. \u015eirket, sa\u011fl\u0131kl\u0131 h\u00fccrelere zarar vermeden belirli kanser mutasyonlar\u0131n\u0131 hedefleyen hassas ila\u00e7lar geli\u015ftiriyor &#8211; bunu kanser tedavisi i\u00e7in ak\u0131ll\u0131 bombalar ile hal\u0131 bombalamas\u0131 aras\u0131ndaki fark olarak d\u00fc\u015f\u00fcnebilirsiniz.<\/p>\n<p>\u0130la\u00e7 adaylar\u0131 \u015funlar\u0131 i\u00e7erir:<\/p>\n<ul>\n<li><strong>Ziftomenib<\/strong>: Akut l\u00f6semiler i\u00e7in Menin inhibit\u00f6r\u00fc (Kyowa Kirin ile ortakl\u0131k)<\/li>\n<li><strong>Tipifarnib<\/strong>: Ba\u015f ve boyun kanserleri i\u00e7in Farnesil transferaz inhibit\u00f6r\u00fc<\/li>\n<li><strong>KO-2806<\/strong>: Erken geli\u015ftirme a\u015famas\u0131nda yeni nesil kanser tedavisi<\/li>\n<\/ul>\n<p>\u015eirketin i\u015f modeli b\u00fcy\u00fck \u00f6l\u00e7\u00fcde stratejik ortakl\u0131klara dayan\u0131yor; <a href=\"https:\/\/dcfmodeling.com\/blogs\/history\/kura-history-mission-ownership\">Nisan 2025 verilerine<\/a> g\u00f6re i\u015f birli\u011fi gelirleri gelirlerinin yakla\u015f\u0131k %95&#8217;ini olu\u015fturuyor. Bu yakla\u015f\u0131m, geli\u015ftirme maliyetlerini ve riskleri payla\u015f\u0131rken pazara \u00e7\u0131k\u0131\u015f s\u00fcresini h\u0131zland\u0131r\u0131yor.<\/p>\n<p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Kura Oncology CEO&#8217;su Troy Wilson, EY Giri\u015fimci Of The Year 2025 Pasifik G\u00fcneybat\u0131 \u00d6d\u00fcl\u00fc&#8217;n\u00fc kazand\u0131 &#8211; bu \u00f6d\u00fcl, \u015firketin yenilik\u00e7i yakla\u015f\u0131m\u0131n\u0131 ve rekabet\u00e7i biyoteknoloji alan\u0131ndaki liderli\u011fini vurguluyor. Bu t\u00fcr \u00f6d\u00fcller genellikle \u00f6nemli kurumsal geli\u015fmeler ve artan yat\u0131r\u0131mc\u0131 ilgisinden \u00f6nce gelir.<\/p>\n"},"faq":[{"question":"Kura Oncology hisseleri nereden al\u0131nabilir?","answer":"Kura Oncology hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online i\u015flem platformu \u00fczerinden KURA sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"Kura Oncology'nin 2025 y\u0131l sonu fiyat hedefi nedir?","answer":"Analistlerin ortalama fiyat hedefi 2025 y\u0131l sonu i\u00e7in 24,69 $ seviyesindedir, bu da mevcut fiyata g\u00f6re %222 y\u00fckseli\u015f potansiyeli anlam\u0131na gelir."},{"question":"Kura Oncology hisseleri y\u00fcksek riskli midir?","answer":"Evet, biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131na ve d\u00fczenleyici onaylara ba\u011fl\u0131 olarak y\u00fcksek volatiliteye sahiptir, bu nedenle y\u00fcksek risk i\u00e7erir."},{"question":"Kura Oncology'nin \u00f6nemli ila\u00e7 adaylar\u0131 nelerdir?","answer":"\u015eirketin \u00f6nemli ila\u00e7 adaylar\u0131 aras\u0131nda Ziftomenib (akut l\u00f6semiler i\u00e7in), Tipifarnib (ba\u015f ve boyun kanserleri i\u00e7in) ve KO-2806 (erken a\u015fama kanser tedavisi) bulunmaktad\u0131r."},{"question":"Yeni ba\u015flayanlar Kura Oncology hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Yeni ba\u015flayanlar k\u00fc\u00e7\u00fck miktarlarla ba\u015flay\u0131p, dolar maliyeti ortalamas\u0131 yaparak, zarar durdur emirleri kullanarak ve \u00f6nemli tarihleri takip ederek yat\u0131r\u0131m yapmal\u0131d\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Kura Oncology hisseleri nereden al\u0131nabilir?","answer":"Kura Oncology hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online i\u015flem platformu \u00fczerinden KURA sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"Kura Oncology'nin 2025 y\u0131l sonu fiyat hedefi nedir?","answer":"Analistlerin ortalama fiyat hedefi 2025 y\u0131l sonu i\u00e7in 24,69 $ seviyesindedir, bu da mevcut fiyata g\u00f6re %222 y\u00fckseli\u015f potansiyeli anlam\u0131na gelir."},{"question":"Kura Oncology hisseleri y\u00fcksek riskli midir?","answer":"Evet, biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131na ve d\u00fczenleyici onaylara ba\u011fl\u0131 olarak y\u00fcksek volatiliteye sahiptir, bu nedenle y\u00fcksek risk i\u00e7erir."},{"question":"Kura Oncology'nin \u00f6nemli ila\u00e7 adaylar\u0131 nelerdir?","answer":"\u015eirketin \u00f6nemli ila\u00e7 adaylar\u0131 aras\u0131nda Ziftomenib (akut l\u00f6semiler i\u00e7in), Tipifarnib (ba\u015f ve boyun kanserleri i\u00e7in) ve KO-2806 (erken a\u015fama kanser tedavisi) bulunmaktad\u0131r."},{"question":"Yeni ba\u015flayanlar Kura Oncology hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Yeni ba\u015flayanlar k\u00fc\u00e7\u00fck miktarlarla ba\u015flay\u0131p, dolar maliyeti ortalamas\u0131 yaparak, zarar durdur emirleri kullanarak ve \u00f6nemli tarihleri takip ederek yat\u0131r\u0131m yapmal\u0131d\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Kura Oncology, Inc. (KURA) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Kura Oncology, Inc. (KURA) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T16:10:43+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Kura Oncology, Inc. (KURA) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T16:10:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/\",\"name\":\"Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Kura Oncology, Inc. (KURA) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"datePublished\":\"2025-08-25T16:10:43+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Kura Oncology, Inc. (KURA) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Kura Oncology, Inc. (KURA) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/","og_locale":"tr_TR","og_type":"article","og_title":"Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Kura Oncology, Inc. (KURA) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T16:10:43+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Kura Oncology, Inc. (KURA) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T16:10:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/","name":"Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Kura Oncology, Inc. (KURA) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","datePublished":"2025-08-25T16:10:43+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Kura Oncology, Inc. (KURA) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":348959,"slug":"how-to-buy-kura-oncology","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Kura Oncology, Inc. (KURA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kura Oncology, Inc. (KURA)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kura-oncology\/"},"pt_AA":{"locale":"pt_AA","id":348958,"slug":"how-to-buy-kura-oncology","post_title":"Como comprar a\u00e7\u00f5es da Kura Oncology, Inc. (KURA) - Investimento em a\u00e7\u00f5es da Kura Oncology, Inc. (KURA)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-kura-oncology\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/348957","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=348957"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/348957\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334009"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=348957"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=348957"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=348957"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}